Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression

The American Journal of Pathology
Alysia A ChavesJohn Anthony Bauer

Abstract

Cardiovascular disease is an important complication of human immunodeficiency virus/acquired immune deficiency syndrome (AIDS), but the mechanism(s) involved are poorly understood. Although co-infecting pathogens have been implicated as an important factor in AIDS progression, no studies have investigated these interactions in cardiac tissue. We recently demonstrated that the murine AIDS model (LPBM5 retroviral infection) mimics human immunodeficiency virus-related cardiac dysfunction and pathology. We tested the hypothesis that subseptic lipopolysaccharide exposure (LPS) would enhance LPBM5 progression and exacerbate cardiovascular dysfunction during murine AIDS development. LPS (5 mg/kg, Escherichia coli 0111:B4) was administered at 1, 6, and 8 weeks during LPBM5 infection, and cardiac performance was evaluated at 10 weeks using noninvasive echocardiography. LPS alone had no significant effects, whereas it amplified abnormalities in cardiac structure and function observed in murine AIDS. Cardiac dysfunction was associated with selective increases in nonfocal infiltration of CD68(+) cells and correlated with the extent of cardiac dysfunction. Retroviral progression and cardiac retroviral content remained unaltered, but cardiac...Continue Reading

References

Apr 1, 1988·Journal of the American College of Cardiology·D W AndersonJ E Parrillo
Sep 4, 1986·The New England Journal of Medicine·I S CohenR R Redfield
Dec 1, 1970·Virology·W P RoweJ W Hartley
Oct 1, 1994·Immunology Today·A Caterino-de-Araujo
May 1, 1994·Circulation·W H Barry
Feb 1, 1993·PCR Methods and Applications·N OgataW G Bradley
Sep 1, 1996·The Journal of Infectious Diseases·A J Cohen, R T Steigbigel
Jan 1, 1996·Viral Immunology·B LiangR R Watson
Aug 1, 1997·Trends in Microbiology·A BlanchardM L Gougeon
Nov 14, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A TietzW Zimmerli
Oct 28, 1998·The Journal of Clinical Investigation·M MoriuchiA S Fauci
Aug 3, 1999·The Journal of Clinical Investigation·S FrantzR A Kelly
Jan 19, 2000·Circulation·R P ShannonA A Lackner
Mar 17, 2000·Immunological Reviews·R Medzhitov, C Janeway
Oct 3, 2000·Progress in Cardiovascular Diseases·W Lewis
Dec 26, 2001·Journal of Clinical Epidemiology·K GoodkinC Eisdorfer
Oct 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Cheryl TwuMilan Fiala
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Murat V KalayogluGerald I Byrne
Feb 15, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S D ChauhanA Ahluwalia
Apr 18, 2003·Frontiers in Bioscience : a Journal and Virtual Library·Majid Sadigh, Sailaja Puttagunta
Jun 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Reshma S BaligaJohn A Bauer

❮ Previous
Next ❯

Citations

Aug 21, 2008·American Journal of Physiology. Endocrinology and Metabolism·Anne M PruznakCharles H Lang
Nov 27, 2007·Progress in Neurobiology·Hervé AllainYvette Akwa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.